South Africa Dermatological Therapeutics Market Analysis Report 2022 to 2030

South Africa Dermatological Therapeutics Market Analysis

$ 3999

South Africa Dermatological Therapeutics Market is at around $0.27 Bn in 2022 and is projected to reach $0.52 Bn in 2030, exhibiting a CAGR of 9.83% during the forecast period. The market is expanding due to a rise in the elderly population, increased awareness and education, and a surge in dermatological conditions. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

ID: IN10ZAPH035 CATEGORY: Pharmaceuticals GEOGRAPHY: South Africa AUTHOR: Aneri Parekh

Buy Now

South Africa Dermatological Therapeutics Market Executive Summary

South Africa Dermatological Therapeutics Market is at around $0.27 Bn in 2023 and is projected to reach $0.52 Bn in 2030, exhibiting a CAGR of 9.83% during the forecast period.

In South Africa, dermatological therapy is essential for treating a broad range of skin ailments, from simple dermatological issues to more complicated diseases. Because of the country's varied climate and diversified population, dermatologists in South Africa use a variety of therapy approaches customized to each patient's specific needs, fusing international best practices with locally relevant remedies. This dynamic field emphasizes how crucial it is to use creative thinking and cultural sensitivity while providing successful skincare interventions across the country.

Growing awareness of dermatological health and an increase in skin-related ailments are driving the steady rise of the South African dermatological therapeutics market. The aging population, increased disposable incomes, and improvements in dermatological care represent significant factors. To take advantage of the new prospects in the South African dermatological treatments sector, market players are concentrating on product innovation and strategic collaborations.

In 2023, the worldwide dermatological treatment market brought in $40.94 Bn, a significant rise over the previous year. Low-cost technologies and contemporary production techniques are the main forces behind this industry transition. The market for dermatological treatments has grown and flourished as a result of the innovative, accessible, and financial assistance combined with accessibility.

The dermatological therapeutics industry in South Africa is dominated by Aspen Pharmacare, a well-known pharmaceutical firm. With a 12.9% value market share, Aspen is the top pharmaceutical business in the South African private sector. In South African pharmacies, an Aspen product is prescribed on about one out of every five prescriptions.

South Africa dermatological therapeutics market

Market Dynamics

Market Growth Drivers:

Growing Dermatological Conditions: The market for dermatological therapies is significantly influenced by the prevalence of skin disorders and diseases. The need for efficient therapies rises along with the prevalence of skin problems.

Increasing Education and Awareness: The availability of cutting-edge dermatological treatments and rising public awareness of the many skin disorders propel market expansion. Better knowledge and early diagnosis are facilitated by educational campaigns and initiatives.

Aging Population: The need for dermatological therapies is being driven by the increasing number of elderly people, who are more likely to experience age-related skin problems. More than 5 Mn people are aged 60 or older. This represents a 9.2 % share of the overall South African population.

Market Restraints:

Economic Factors: Consumer spending on healthcare, especially dermatological medicines, can be impacted by economic difficulties and changes.

Regulatory Obstacles: Tight rules and lengthy approval procedures for novel dermatological products may impede market expansion.

Limited Healthcare Infrastructure: Dermatological treatments may be more difficult to obtain in remote locations due to a lack of adequate healthcare infrastructure.

Healthcare Policies and Regulatory Landscape

SAHPRA, the South African Health Products Regulatory Authority, is the regulatory body in charge of approving pharmaceuticals in the nation. The applicant company created the product dossier, which is regarded as a legal contract that must be approved by the Medicines Control Council (MCC). The medicine's Certificate of Registration, which doubles as a sales permission, attests to this. Any modifications the business makes after registering require MCC approval. Because SAHPRA lacks the resources of wealthy nations, timelines may be further extended.

Competitive Landscape

Key Players:

Aspen Pharmacare
Adcock Ingram
Pfizer Inc.
GlaxoSmithKline Plc.
AbbVie Inc.
Amgen Inc.
Novartis AG
Roche
Sanofi
Bayer
Johnson & Johnson

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

South Africa Dermatological Therapeutics Market Segmentation

By Type

Prescription-based Drugs
Over-the-counter Drugs

By Disease

Alopecia
Herpes
Psoriasis
Rosacea
Skin Cancer
Acne
Atopic Dermatitis
Vitiligo
Hidradenitis
Other Applications

By Drug Class

Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Other Drug Classes

By Route of Administration

Topical Administration
Oral Administration
Parenteral Administration

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.